Blood Screening Markets, 2027 by Product (Reagents & Kits, Instruments, Software), Technology (NAAT, ELISA, Rapid Tests, Western Blotting, NGS), and End User (Blood Banks, Hospitals, Laboratories) - ResearchAndMarkets.com
The blood screening market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach $3.56 billion by 2027.
- The blood screening market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach $3.56 billion by 2027.
- The main driving factors are increasing blood donations and transfusion-related screening, the rising prevalence of infectious diseases, the growing geriatric population, and increasing awareness regarding transfusion-transmitted diseases.
- Based on technology, the nucleic acid amplification segment accounted for the largest share of this market in 2020.
- Based on end user, the blood banks segment accounted for the largest share of this market in 2020.